Analysis of antibody response in human dengue patients from the Mexican coast using recombinant antigens

Vector-Borne and Zoonotic Diseases

Volumn 8, Issue 1, 2008, Pages 69-79

  Lazaro Olan L ^a   Mellado Sanchez G ^b   Garcia Cordero J ^a   Escobar Gutierrez A ^c   Santos Argumedo, L ^a   Gutierrez Castaneda B ^d   Cedillo Barron L ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Antibodies; Dengue antigens; Dengue serology; Dengue virus

Indexed keywords

GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4B; PEPTIDE E; RECOMBINANT ANTIGEN;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; MEXICO; MOLECULAR CLONING; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

DENGUE VIRUS; ESCHERICHIA COLI;

EID: 39449092236     PISSN: 15303667     EISSN: None     Source Type: Journal    
DOI: 10.1089/vbz.2007.0117     Document Type: Article

References (36)

1. AbuBakar, S, Azmi, A, Mohamed-Saad, N, et al. Antibody responses of dengue fever patients to dengue 2 (New Guinea C strain) viral proteins. Malays J Pathol 1997; 19:41-51.
2. AbuBakar, S, Azila, A, Suzana, M, et al. Antigenic cell associated dengue 2 virus proteins detected in vitro using dengue fever patients sera. Malays J Pathol 2002; 24:29-36.
3. Alcon, S, Talarmin, A, Debruyne, M, et al. Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002; 40:376-381.
4. Anandarao, R, Swaminathan, S, Fernando, S, et al. Recombinant multiepitope protein for early detection of dengue infections. Clin Vaccine Immunol 2006; 13:59-67.
5. Berasain, C, Garcia-Granero, M, Riezu-Boj, JI, et al. Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides. J Hepatol 1993; 18:80-84.
6. Bisht, H, Chugh, DA, Raje, M, et al. Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen. J Biotechnol 2002; 99:97-110.
7. Boletin de Epidemiologia. Semana 52. Secretaria de Salud México, Centro Nacional de Vigiláncia Epidemiológica. 2007.
8. Churdboonchart, V, Bhamarapravati, N, Peampramprecha, S, et al. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am J Trop Med Hyg 1991; 44:481-493.
9. Cortes, LM, Barth, OM, Pantoja, JR, et al. Comparative immunological recognition of proteins from New Guinea "C" dengue virus type 2 prototype and from a dengue virus type 2 strain isolated in the state of Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 2003; 98:331-334.
10. dos Santos, FB, Miagostovich, MP, Nogueira, RM, et al. Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response. Am J Trop Med Hyg 2004; 71:144-152.
11. Flisser, A, Velasco-Villa, A, Martinez-Campos, C, et al. Infectious diseases in Mexico. A survey from 1995-2000. Arch Med Res 2002; 33:343-350.
12. Gruenberg, A, Woo, WS, Biedrzycka, A, et al. Partial nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue virus type 2, New Guinea C and PUO-218 strains. J Gen Virol 1988; 69:1391-1398.
13. Gubler, DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10:100-103.
14. Guzman, MG, Kouri, G. Dengue: an update. Lancet Infect Dis 2002; 2:33-42.
15. Guzman, MG, Vazquez, S. [Notes on the laboratory diagnosis of dengue virus]. Rev Cubana Med Trop 2002; 54:180-188.
16. Huang, JL, Huang, JH, Shyu, RH, et al. High-level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen. J Med Virol 2001; 65:553-560.
17. Katrak, K, Mahon, BP, Jones, WC, et al. Preparative separation of foreign antigens for highly efficient presentation to T cells in vitro. J Immunol Methods 1992; 156:247-254.
18. Koraka, P, Suharti, C, Setiati, TE, et al. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J Clin Microbiol 2001; 39:4332-4338.
19. Kuno, G, Vorndam, AV, Gubler, DJ, et al. Study of anti-dengue NS1 antibody by Western blot. J Med Virol 1990; 32:102-108.
20. Lanciotti, RS, Calisher, CH, Gubler, DJ, et al. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30:545-551.
21. Lindenbach, BD, Rice, CM. Molecular biology of flaviviruses. Adv. Virus Res 2003; 59:23-61.
22. Littaua, R, Kurane, I, Ennis, FA. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 1990; 144:3183-3186.
23. Mady, BJ, Erbe, DV, Kurane, I, et al. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. J Immunol 1991; 147:3139-3144.
24. Mellado-Sanchez, G, Garcia-Cordero, J, Luria-Perez, R, et al. DNA priming E and NS1 constructs - homologous proteins boosting immunization strategy to improve immune response against dengue in mice. Viral Immunol 2005; 18:709-721.
25. Morens, DM, Halstead, SB. Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J Gen Virol 1990; 71:2909-2914.
26. Mukhopadhyay, S, Kuhn, RJ, Rossmann, MG. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 2005; 3:13-22.
27. Roehrig, JT. Antigenic structure of flavivirus proteins. Adv Virus Res 2003; 59:141-75.
28. Schlesinger, JJ, Brandriss, MW, Walsh, EE. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol 1987; 68:853-857.
29. Schlesinger, JJ, Foltzer, M, Chapman, S. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 1993; 192:132-141.
30. Se-Thoe, SY, Ng, MM, Ling, AE. Retrospective study of Western blot profiles in immune sera of natural dengue virus infections. J Med Virol 1999; 57:322-330.
31. Simmons, M, Murphy, GS, Kochel, T, et al. Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine. Am J Trop Med Hyg 2001; 65:420-426.
32. Tan, CH, Yap, EH, Singh, M, et al. Passive protection studies in mice with monoclonal antibodies directed against the non-structural protein NS3 of dengue 1 virus. J Gen Virol 1990; 71:745-749.
33. Valdes, K, Alvarez, M, Pupo, M, et al. Human dengue antibodies against structural and nonstructural proteins. Clin Diagn Lab Immunol 2000; 7:856-857.
34. Valerio, L, de Balanzo, X, Jimenez, O, et al. [Haemorrhagic exanthema due to dengue virus induced by acetylsalicylic acid]. An Sist Sanit Navar 2006; 29:439-442.
35. Videa, E, Coloma, MJ, dos Santos, FB, et al. Immunoglobulin M enzyme-linked immunosorbent assay using recombinant polypeptides for diagnosis of dengue. Clin Diagn Lab Immunol 2005; 12:882-884.
36. Wong, SJ, Boyle, RH, Demarest, VL, et al. Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol 2003; 41:4217-4223.